Delivery Order SPE2DB22D2005-SPE2DB25FJRT3
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,076.30 for 240mL of Suprane inhalation liquid, with an ultimate completion date of August 20, 2025. This contract represents a firm fixed price delivery order with no set-aside designation, competitively awarded on August 19, 2025. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order falls under...
- The Defense Logistics Agency awarded a $5,379.52 delivery order to AmerisourceBergen Drug Corp for Suprane Inhalation Liquid 240ML, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Suprane inhalation liquid (240ml) with a ceiling value of $1,533.31 and a firm fixed price contract type. The delivery order is not set-aside and represents a competitive award, with an ultimate completion date of July 29, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,076.30 by the Defense Logistics Agency on August 1, 2025, for the supply of Suprane Inhalation Liquid (240ml), an anesthetic agent used in surgical and medical procedures. The contract carries a firm fixed price structure with no set-aside designation, indicating it was awarded through competitive procurement. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for the supply of SUPRANE INHALATION LIQUID 240ML, a pharmaceutical product, with a ceiling value of $2,599.03 and a performance period through April 1, 2024. This award is associated...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,696.72 to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG Inhaler 10.7GM pharmaceutical products. This firm fixed-price, non-set-aside delivery order was awarded on July 24, 2025, with an ultimate completion date of July 25, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $1,074.36 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 240ml Suprane inhalation liquid. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and various Department of Defense customers. Performance will take place in Conshohocken, Pennsylvania over a period of four days from July 21 through July 24, 2023. No subcontractors or set...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,414.08 on July 24, 2025, for the supply of Sevoflurane inhalation liquid in 250ml quantities. The contract is a firm fixed price delivery order with an ultimate completion date of July 25, 2025, and is funded by the Defense Logistics Agency's Medical Supply Chain division. This award was made through open competition with no set-aside designation,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,780.81 by the Defense Logistics Agency (DLA) on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract, designated as a child order under a larger indefinite delivery contract (IDC), covers the supply of Ultane 250 mL pen bottle medication. This delivery order was competitively awarded with firm fixed-price pricing...
- The Defense Logistics Agency awarded a $2,560.18 firm fixed price delivery order to AmerisourceBergen Drug Corp for AIRSUPRA 90-80 MCG inhaler 10.7GM, with an ultimate completion date of August 6, 2025. This non-set-aside contract represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order will be fulfilled from the contractor's corporate office...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB25FJRT3Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,746.56 for Suprane Inhalation Liquid (240ml) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle extending through December 2026 that enables the company to supply a comprehensive range of medications and medical supplies to military healthcare programs worldwide. AmerisourceBergen Drug Corp serves as a critical vendor within the Defense Health Agency's medical supply chain, fulfilling federal pharmaceutical procurement needs through its extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies. As a major pharmaceutical distributor based in Pennsylvania, the company has demonstrated capability to meet competitive federal procurement standards across multiple therapeutic domains. This delivery order for inhalation anesthetic products supports military and veteran healthcare systems' operational requirements through the established DLA prime vendor relationship, which DLA intends to expand under its Pharmaceutical Prime Vendor Global Program Generation V initiative with multiple regional contracts.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/14/25 |